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3′-Deoxy-3′-fluorothymidine (FLT, alovudine®) belongs to the most potent agents inhibiting HIV-1
replication. Its 5′-triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse transcriptase (HIV RT).
Unfortunately, FLT exerts substantial hematologic toxicity both in vitro and in vivo. It was suggested
that this toxicity may be related to inhibition of human DNA polymerases, especially mitochondrial DNA
polymerase , by nucleoside analogue 5′-triphosphates leading to termination of DNA synthesis and
mitochondrial dysfunction. To decrease the toxicity of FLT, its thiated analogues, 4-SFLT and 2-SFLT,
were previously synthesized and shown to be potent inhibitors of HIV-1 with low in vitro cytotoxicity. To
explain this phenomenon in the present study the synthesis of 5′-triphosphates of thiated FLT analogues
was undertaken and their interaction with recombinant HIV-1 RT and human DNA polymerases  (pol )
and  (pol ) was investigated. It was shown that 3′-deoxy-3′-fluoro-4-thiothymidine 5′-triphosphate
(4-SFLTTP) and 3′-deoxy-3′-fluoro-2-thiothymidine 5′-triphosphate (2-SFLTTP) were, similarly to FLTTP,
potent competitive inhibitors of HIV-1 RT, with Kappi values of 0.091 and 0.022M respectively. It is
of interest that 2-SFLTTP, a compound in an unusual syn conformation around the glycosidic bond
was an uncompetitive inhibitor of human mitochondrial DNA pol  with Kappi of 0.174M, while 4-
SFLTTP in anti conformation inhibited this enzyme similarly to FLTTP, i.e., non-competitively, with Kappi
of 0.055M. Both 4-SFLTTP and 2-SFLTTP were competitive inhibitors of human DNA pol , with Kappi
values of 16.84 and 4.04M, respectively. The results point to partially selective inhibition of HIV RT by
thiated 3′-fluorothymidine 5′-triphosphate analogues. Of special interest is that 2-SFLTTP, showing syn
conformation, is a less potent inhibitor of human mitochondrial pol  than 4-SFLTTP and FLTTP, both in
the anti conformation, and has a higher inhibitory activity against HIV-1 RT than 4-SFLTTP. Moreover, the
parent nucleoside 2-SFLT possessing the syn conformation shows a more potent anti-HIV-1 activity and
a better selectivity index than its 4-thio isomer in the anti conformation (Matthes et al., 1989; Poopeiko
et al., 1995), 2-SFLT is a potent and selective anti-HIV-1 agent with the selectivity index 4-fold higher
than that of FLT.
Findings regarding the mechanisms of antiviral and cytotoxic activities of FLT and its thioanalogues
are discussed.
. Introduction
Multidrug, highly active antiretroviral therapy (HAART)
mployed in the treatment of human immunodeficiency virus
HIV) infection uses as its main components nucleoside inhibitors
f HIV reverse transcriptase (NRTIs). It was suggested that long
erm therapywith theNRTIsmay be associatedwithmitochondrial
NA polymerase  (pol ) inhibition and subsequent depletion of
itochondrial DNA (Kaguni, 2004; Kakuda, 2000). However, the
∗ Corresponding author. Fax: +48 22 592 21 90.
E-mail address: tk@ibb.waw.pl (T. Kulikowski).
166-3542/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
oi:10.1016/j.antiviral.2010.08.011© 2010 Elsevier B.V. All rights reserved.
DNA pol  hypothesis by itself fails to explain the entire array of
metabolic deficiencies associated with NRTI-induced disorders.
Direct effects of NRTI’s on various mitochondrial targets must also
be taken into account (Lund and Wallace, 2004).
3′-Deoxy-3′-fluorothymidine (FLT, alovudine®) belongs to the
most potent agents inhibiting HIV-1 replication. In addition, it
is highly active against HIV-1 multidrug resistant (MDR) strains.
Its 5′-triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse
transcriptase (HIV RT, RNA-directed DNA polymerase, EC 2.7.7.49)
(Cheng et al., 1987). Unfortunately, FLT displays high cytotoxicity
against host cells which limits its clinical applicability (Balzarini
et al., 1988). It was suggested that this toxicity may be related to
inhibition of humanDNApolymerases (EC 2.7.7.7), especiallymito-
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hondrial DNA polymerase , by FLT metabolite—5′-triphosphate,
eading to termination of DNA synthesis and mitochondrial dys-
unction (Kaguni, 2004). To decrease the cellular toxicity of FLT,
ts thiated analogues 4-SFLT and 2-SFLT were previously prepared
nd shown to bepotent in vitro inhibitors ofHIV-1with low toxicity
Matthes et al., 1989; Poopeiko et al., 1995). To establish whether
nhibition of pol  exerted by thiated FLTTP analogues is corre-
ated with development of in vitro cytotoxicity in cell cultures, we
ecided to synthesise 2-SFLTTP, 4-SFLTTP as well as FLTTP and
o investigate their interactions with recombinant HIV-1 RT and
uman polymerases  and .
. Materials and methods
.1. Chemicals
[Methyl-3H] dTTP (45.9Ci/mmol) was purchased from Moravek
iochemicals Inc., Brea, CA; nucleotides and activated calf thymus
NA were from Sigma; AZTTP was purchased from Calbiochem;
oly(rA)·p(dT)12–18 and HIV reverse transcriptase were from GE
ealthcare (Amersham Biosciences); DE81 (2.3 cm) circles were
rom Whatman. Triton X-100 and rotiszint eco plus LSC-universal
ocktail were from Roth. Recombinant human DNA polymerases
and  were provided by EURx Ltd. (Gdan´sk, Poland). All other
eagents used in this study were of analytical grade.
.2. Synthesis of thiated nucleoside 5′-triphosphates
The syntheses of 5′-triphosphates of 2-SFLT, 4-SFLT as well as
LT (Fig. 1) were performed with the use of modified Vrang pro-
edure (Vrang et al., 1987) employing direct phosphorylation of
nprotected nucleosides.
.3. Assays of HIV-1 reverse transcriptase and human DNA
olymerases  and ˇ activities
The activities of HIV-1 RT and both human polymerases were
ssayed by DE81 filter isotopic method (Reardon and Miller,
990). Unless otherwise indicated, reaction mixtures for RT activ-
ty studies contained 50mM KCl, 50mM Tris–HCl, pH 7.8, 13mM
odium phosphate buffer, pH 7.0, 10mM MgCl2, 0.02% Triton X-
00, 0.33mM DTT, 20M [3H]dTTP (128–180DPM/pmol), 9g/ml
oly(rA)·p(dT)12–18 and 14ng HIV reverse transcriptase. Reac-
ion mixture for pol  contained 25mM HEPES-KOH (pH 8.0),
mM Tris–HCl (pH 8.0), 0.25mM DTT, 0.5mM MnCl2, 2.5mM
-ME, 10g acetylated BSA, 0.01% Triton X-100, 5M [3H]dTTP
4×103 DPM/pmol), 0.1M NaCl, 20g/ml poly (rA)·oligo(dT)12–18
nd 98ng of polymerase . Reaction mixture for pol  contained
0mM Tris–HCl (pH 7.8), 10mM MgCl2, 0.4mg/ml of BSA, 2.5mM
TT, 100mM KCl, 5mM NaCl, 0.01% Triton X-100, 50M dNTP
specific activity of [3H]dTTP was 2×102 DPM/pmol), 300g/ml
ctivated calf thymus DNA and 18ng of polymerase . All the
eaction mixtures were initiated with enzyme in a total volume
f 20–30l and incubated at 37 ◦C and performed for 30min.
0–15l of a reaction mixture was spotted onto DE81 (2.3 cm)
aper circle. In order to remove unincorporated [3H]dTTP, the cir-
les were washed 3× with 5% Na2HPO4, 3× with distilled water
nd once with 95% ethanol. After placing the dry circles in scintil-
ation flasks, 300l of the elution mixture (0.2M KCl, 0.1M HCl)
as added. The amount of [3H]dTMP incorporated into template
nd adsorbed on the circle was determined in scintillation cocktail
sing a PerkinElmer® scintillation counter.arch 88 (2010) 176–181 177
2.4. Steady-state kinetic assays
The appropriate concentrations of each inhibitor used for the
Kappi determination were calculated using the Cheng and Prusoff
equationKi = IC50/(1 + [S]/Km)where [S] andKm were theconcentra-
tion and affinity of the radioligand, respectively (Cheng and Prusoff,
1973). Kappi values for HIV-1 RT inhibition were determined at
minimum two concentrations of each compound tested and four
concentrations of dTTP in the range of 1–32M and at saturat-
ing poly(rA)·p(dT)12–18 concentration of 9g/ml. Kappi values for
human pol  inhibition were determined at two to three concen-
trations of each inhibitor tested and four concentrations of dTTP in
the range of 1.5–12M and at saturating poly(rA)·p(dT)12–18 con-
centration of 20g/ml.Kappi values for humanpol inhibitionwere
determined at two concentrations of each inhibitor tested and four
concentrations of dTTP in the range of 40–320M and saturating
concentration of activated calf thymus DNA of 300g/ml. Vappmax,
Kappm and K
app
i values were calculated using nonlinear regression
by fitting of the experimental data to the appropriate equations
in GOSA fit (Global Optimization by Simulated Annealing) Bio-Log
software. To determine the type of inhibition, the experimental
data were fitted to the general equation for reversible inhibition
in GOSA fit, and, additionally, the double-reciprocal plots of dTMP
incorporation rate into template–primer and dTTP concentration
dependence in the presence of several inhibitor concentrations
(Lineweaver–Burk plots) were generated.
2.5. NMR-based conformational analysis
All the spectra of nucleoside 5′-triphosphates and the corre-
sponding nucleosides were recorded for their aqueous solutions
at 298K on 500MHz Varian Unity Plus spectrometer. The spec-
tra were processed with the aid of MestRec 4.56 using /4 shifted
sine-bell filter followed by Lorenzian smoothing resulting in 0.5Hz
line broadening and zero-filling up to 32k data points prior to
Fourier transformations. The resonance signals of nucleosideswere
assigned on the basis of the geminal and vicinal scalar couplings
extracted from the spectra and verified by comparison of the
simulated and experimental spectra. The assignment of those of
triphosphates was adopted from the spectra of the corresponding
nucleosides. Due to significant broadening of the resonance lines,
no furanose ring puckering analysis could have been applied for
nucleoside 5′-triphosphates, and only syn–anti preferences about
the glycosidic bond were followed by the analysis of the two pro-
posed discriminators—e.g., chemical shift of H1′ and the separation
of H2′ and H2′′ resonances, both of which were previously proven
sensitive to relative orientation of ribose and pyrimidine moieties
(Poznan´ski et al., 2000).
3. Results and discussion
3.1. Kinetics of incorporation of dTMP
The rates of dTMP incorporation into poly(rA)·p(dT)12–18
by HIV-1 RT and human DNA polymerase  and into acti-
vated DNA by human DNA pol  were linear with respect to
time and enzyme concentration with Vappmax values of 370±99,
0.23±0.05 and 64±15nmolmin−1 mg−1 protein, respectively; the
template–primer concentrations used in the assays did not inhibit
the enzyme activity (Majumdar et al., 1988). The Kappm value
obtained for dTTP for HIV-1 RT (9.05±0.46M) was similar to the
values determined by others with the use of poly(rA)·p(dT)12–18
(Matthes et al., 1989; Reardon and Miller, 1990), whereas Kappm val-
ues for the substrate obtained for the studied recombinant human
DNApolymerases and (2.61±0.19Mand 78±14M, respec-
178 P. Win´ska et al. / Antiviral Research 88 (2010) 176–181
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tig. 1. Structures and conformations around glycosidic bond of 3′-deoxy-3′-fluor
4-SFLT) and 3′-deoxy-3′-fluorothymidine (FLT, FLTTP, B).
ively) were significantly higher than those reported for the native
olymerases isolated from mammalian cells and assayed with the
se of the same template–primers as in the present study (Faraj
t al., 2000; Hart et al., 1992; Martin et al., 1994). However, the
bserveddifferencebetween theKappm values for dTTP for bothpoly-
erases studied was similar to that demonstrated by others, and
he low Kappm for pol  was diagnostic for this polymerase (Hart et
l., 1992; Martin et al., 1994).
.2. Effects of 4-SFLTTP and 2-SFLTTP on HIV-1 reverse
ranscriptase and human DNA polymerases  and ˇ
FLTTP and AZTTP were used in the present study as controls
n HIV-1 RT and human DNA polymerases inhibition assays. The
esults obtained for inhibition of HIV-1 RT and human polymerase
and by the tested compounds are presented in Table 1. Enzyme
inetic studies with HIV-1 RT (Lineweaver–Burk plots) showed
hat both 4-SFLTTP and 2-SFLTTP were, similarly to the parent
ompound and to AZTTP, competitive inhibitors of this enzyme
ith respect to dTMP incorporation into poly(rA)·p(dT)12–18. Kappi
alues for both control inhibitors for HIV-1 RT inhibition with
oly(rA)·p(dT)12–18 were within the range of values reported in
he literature (Cheng et al., 1987; Hart et al., 1992; Matthes et al.,
990;ReardonandMiller, 1990). 4-SFLTTPwasabout threeand four
able 1
n vitro anti-HIV-1 activity of thymidine nucleoside analogues and inhibition constants of
riphosphates.
Nucleoside Anti-HIV-1
activity
EC50 [M]a
Cytotoxicity
CC50 [M]b
Selectivity
index (SI)
(CC50/EC50)
Enzyme inhibition
HIV RT
Nucleotide Kap
i
AZT 0.003e 4.81e 1603 AZTTP 0.0
FLT 0.001e 0.197e 197 FLTTP 0.0
4-SFLT 1.0f 480f 480 4-SFLTTP 0.0
2-SFLT 0.269g 223g 828 2-SFLTTP 0.0
a 50% effective concentration, or concentration required to inhibit HIV-induced cytopa
b 50% cytotoxic concentration, or concentration required to reduce the viability of MT-
c In all other cases, inhibition was competitive with respect to dTTP.
d The results are presented as means± SD, calculated from three independent experim
e Balzarini et al. (1989).
f Matthes et al. (1989).
g Poopeiko et al. (1995).iothymidine, its 5′-triphosphate (2-SFLT, A), 3′-deoxy-3′-fluoro-4-thiothymidine
times less inhibitory to HIV-1 RT than FLTTP and AZTTP, respec-
tively (Table 1). In contrast, 2-SFLTTP exhibited exactly the same
inhibitory effect toward HIV-1 RT as AZTTP and slightly greater
than FLTTP. The obtained difference between the activity of 4-
SFLTTP and the parent compound, FLTTP, toward HIV-1 RT was
in agreement with the results previously reported (Matthes et al.,
1989).
4-SFLTTP and 2-SFLTTP were found to be effective inhibitors
of human DNA polymerase . Interestingly, 2-SFLTTP acted as an
uncompetitive inhibitor of this polymerase with respect to dTMP
incorporation into poly(rA)·p(dT)12–18 (Fig. 2A), whereas 4-SFLTTP
inhibited this enzyme similarly to FLTTP, i.e., non-competitively
(Fig. 2B). AZTTP was found to be a mixed inhibitor of human DNA
pol with respect to dTMP incorporation into poly(rA)·p(dT)12–18,
with both competitive and uncompetitive mechanisms of inhibi-
tion operating with different Kappi values for each of the two types
of inhibitor action. The same type of inhibition for AZTTP with sim-
ilar Kappi values was reported by others, when poly(rA)·p(dT)12–18
was used as the template–primer for mitochondrial polymerase
(Lewis et al., 1994). The presented data indicate that 4-SFLTTP,
similarly to control inhibitors, FLTTP and AZTTP, can bind both
the free enzyme and the enzyme–substrate complex, but unlike
AZTTP, binds with the same affinity, whereas 2-SFLTTP binds
only the enzyme–substrate complex. The obtained results are
HIV-1 reverse transcriptase and human DNA polymerases  and  for the adequate
Human pol  Human pol 
p ± SD [M] Type of inhibitionc Kapp
i
± SD [M] Kapp
i
± SD [M]
22 ± 0.005d Mixed K1
i
= 2.3 ± 0.09
K2
i
= 9.56 ± 0.67
422 ± 38
31 ± 0.001 Non-competitive 0.054±0.016 2.8 ± 0.39
91 ± 0.009 Non-competitive 0.055±0.023 16.84 ± 2.86
22 ± 0.004 Uncompetitive 0.174±0.049 4.04 ± 0.12
thogenicity in MT-4 cells.
4 cells.
ents.
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Table 2
1H resonance assignment of the ribose protons, and the difference, ı(H2′2′′), between H2′ and H2′′ resonances, which was found indicative for syn–anti conformation.
H6 H1′ H2′ H2′′ H3′ H4′ H5′ H5′′ H2′2′′
FLT 7.55 6.23 2.26 2.51 5.22 4.25 3.69 0.25
2-SFLT 7.77 6.95 2.12 2.77 5.23 4.33 3.74 0.64
FLTTP 7.66 6.31 2.28 2.50 5.41 4.08 4.16 0.22
2S-FLTTP 7.84 6.98 2.19 2.74 5.44 4.13 4.19 0.55
4S-FLT 7.72 6.29 2.36 2.67 5.31 4.38 3.78 0.32
24diS-FLT 8.02 6.84 2.15 2.70 5.32 4.32 3.70 0.55
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(4S-FLTTP 7.72 6.27 2.29 2.57
2,4diS-FLTTP 7.83 6.90 2.17 2.84
dUrd 7.83 6.27 2.36 2.40
2S-dUrd 7.03 2.38 2.70
ather intriguing and difficult to explain, however, lack of recog-
ition of studied compounds as thymidine analogues by pol 
ight be important reason, that inhibition is not competitive
ith respect to dTTP. It was demonstrated that AZTTP was non-
ompetitive inhibitor of HIV RT with respect to other nucleotides
han dTTP (König et al., 1989). In the case of 2-SFLTTP, it could
e possible, that its syn conformation contributed to the untypi-
al mechanism of inhibition. Furthermore, the influence of some
hysico-chemical properties of studied recombinant pol  (num-
er of free –SH or lack of some posttranslational modifications)
r/and additionally template dependence may be also taken into
onsideration.
It is noteworthy that 2-SFLTTP in contrast to FLTTP and 4-
FLTTP (no selectivity was observed) was several fold more
elective toward HIV-1 RT than toward human pol , although,
t was less selective than AZTTP (Table 1). In comparison to
LTTP and its thionucleotides, AZTTP was found in the present
tudy to be a relatively weak inhibitor of human DNA pol ,
hich is consistent with the literature data demonstrating inhi-
ig. 2. Lineweaver–Burke plots of humanDNApolymerase inhibition by 2-SFLTTP
A) and 4-SFLTTP (B).5.41 4.10 4.17 0.28
5.42 4.20 4.20 0.67
4.45 4.03 3.82 3.74 0.04
4.52 4.19 3.97 3.88 0.32
bition of this polymerase by AZTTP and other ddNTP (Hart et
al., 1992; Martin et al., 1994; Parker et al., 1991). The results
obtained for human pol  inhibition were in agreement with
other studies demonstrating that human DNA pol  is unique
among the cellular replicative DNA polymerases in that it is
highly sensitive to inhibition by anti-HIV nucleotide analogues
(Johnson et al., 2001; Lee et al., 2003; Lim and Copeland, 2001;
Martin et al., 1994; Parker et al., 1991). It was demonstrated that
mitochondrial polymerase readily incorporated 2′,3′-dideoxy-CTP
(ddCTP), 2′,3′-dideoxy-ITP (ddITP) and 2′,3′-didehydro-3′-deoxy-
TTP (D4T-TP) with an efficiency similar to the incorporation of
normal nucleotides, whereas AZTTP, carbocyclic 2′,3′-didehydro-
ddGTP (CBV-TP) and (−)-2′,3′-dideoxy-3′-thiacytidine-TP (3TC-TP)
acted as only moderate inhibitors of this enzyme (Bienstock and
Copeland, 2004; Eriksson et al., 1995; Hanes and Johnson, 2008;
Lim and Copeland, 2001).
Enzyme kinetic studies with human DNA pol  demonstrated
that both 4-SFLTTP and 2-SFLTTP, similarly to AZTTP and FLTTP
were competitive inhibitors of that enzyme with respect to dTMP
incorporation into activated DNA. The data obtained for inhibition
of pol  by 4-SFLTTP and FLTTP were consistent with the previ-
ously reported results, demonstrating 4-SFLTTP to be less effective
than FLTTP (Matthes et al., 1987, 1989). The reported Kappi values
for AZTTP inhibition of dTMP incorporation into endonuclease-
activated DNA vary for this polymerase between 0.67 and 810M.
The reason for this dramatic disparity is not clear. However, AZTTP
in the most cases was a less potent inhibitor of polymerase 
than the ddNTPs (Copeland et al., 1992; Hart et al., 1992; Martin
et al., 1994). In the present study, AZTTP was found to be an
over 100-fold less potent inhibitor of human pol  than FLTTP,
which is in agreement with the literature data (Martin et al.,
1994). The observed general inhibitory effect of the studied com-
pounds was reported for other NRTIs (Kakuda, 2000), with the
following hierarchy: HIV-1 RT>human pol >human pol , with
the exception of 4-SFLTTP (higher Kappi for HIV-1 RT than for pol
).
3.3. NMR-based conformational analysis
The different interaction of the 2- and 4-thio FLTTP analogues
with polymerase  is intriguing and may be due to the different,
unusual syn conformation around the glycosidic bond of the 2-
thio FLT analogues (Fig. 1A), in contrast to FLT itself and to its
4-thio analogue which show typical for natural nucleosides con-
formation anti (Fig. 1B). This was more precisely analysed with
the aid of NMR spectroscopy. The resonance assignment is sum-
marised in Table 2. On the basis of the data obtainedpreviously for a
series of variously substituted  and  2′-deoxyuridine derivatives
(Remin, 2001),wehavepreviously found that the separationof2′,2′′
methylene group resonances is indicative of a syn–anti equilibrium.
Consequently, the data presented in Fig. 3 clearly indicate that FLT,
FLTTP, 4-S-FLT, 4-S-FLTTP and dUrd are in an anti conformation,
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hile in their 2-S substitutedderivatives, 2-S-FLT, 2-S-FLTTP, 2,4-S-
LT, 2,4-S-FLTTP and 2-S-dUrd the syn conformation predominates
Fig. 3).
.4. Inhibition of enzymes versus in vitro anti-HIV-1 activity of
-SFLT and 2-SFLT
The presented results do not show much correlation with the
nti-HIV-1 in vitro studies on syncytia-inducing laboratory HIV-1
train in MT-4 cells, which demonstrate that 2-SFLT and 4-SFLT
nhibit viral growth with EC50 of 0.269 and 1.0M (Table 1),
espectively, with very low cytotoxicity observed (CC50 of 223
nd 480M, respectively) (Matthes et al., 1989; Poopeiko et al.,
995). 2-SFLT and 4-SFLT were several orders of magnitude weaker
nhibitors of HIV replication than FLT (EC50 0.001M) (Balzarini et
l., 1989), whereas Kappi values obtained for the inhibition of HIV-1
T by their triphosphates were comparable and 3-fold higher than
hat for FLTTP, respectively (Table1).However, it is noteworthy that
-SFLTTP was a nearly 4-fold weaker inhibitor of HIV-1 RT than 2-
FLTTP, and a similar relation between EC50 values for the adequate
hionucleosides was observed in in vitro anti-HIV-1 activity studies
Matthes et al., 1989; Miazga et al., 2003; Poopeiko et al., 1995).
There was no correlation between the obtained Kappi values for
uman pol  and pol  inhibition by 5′-triphosphates of FLT and
ts two thionucleosides (Table 1) and the cytotoxicity observed
n in vitro tests. 4-SFLT and 2-SFLT exerted very low cytotoxicity
n comparison to FLT (CC50 of 480, 223 and 0.197M, respec-
ively) (Balzarini et al., 1989; Matthes et al., 1989; Poopeiko et
l., 1995). The above results are in contrast to the observation
hat 4-SFLTTP and 2-SFLTTP inhibit pol  similarly and only 4-fold
ess than FLTTP, respectively, and, moreover, 1–2 orders of mag-
itude more strongly than AZTTP (Table 1). On the other hand,
ZT exerts much stronger cytotoxicity than thionucleosides with
C50 =4.81M (Balzarini et al., 1989). Furthermore, both thionu-
leoside 5′-triphosphates were found to be much more effective
nhibitors of human DNA pol  than AZTTP, but, respectively com-
arable and 6-fold less effective inhibitors of DNA pol  in the case
f 2-SFLTTP and 4-SFLTTP as compared to FLTTP (Table 1). The data
n pol  inhibition are in line with previous results, obtained with
ther nucleoside analogues, which point to the lack of a universal
echanism of mitochondrial toxicity exerted by NRTIs (Lund and
allace, 2004; Lund et al., 2007). The poor correlation between
nhibition of HIV-1 RT and humanDNApolymerases and the effects
n cells was observed for many other NRTIs including analogues of
hymidine triphosphate, such as ddTTP and d4TTP (Martin et al.,
994). Obviously, a precise correlation between enzyme inhibition
ig. 3. Conformation of FLT, FLTTP, 4-S-FLT, 4-S-FLTTP and dUrd and their 2-S sub-
tituted derivatives, 2-S-FLT, 2-S-FLTTP, 2,4-S-FLT, 2,4-S-FLTTP and 2-S-dUrd.arch 88 (2010) 176–181
and the effects on cells cannot be expected, because of numer-
ous differences in the assays. The templates and primers used in
the present study, poly(rA)·p(dT)12–18 and activated calf thymus
DNA, were artificial and differed from those the enzymes might
encounter in HIV-1 infected cells. Different templates and primers
will give rise to binary enzyme-template and primer complexes
whose interactions with a particular nucleotide might result in sig-
nificantly different Kappi values (Hart et al., 1992). Many processes
of intracellular metabolism of nucleoside analogues, like reduc-
tion, oxidation, glycosylationandphosphorylationofnucleosides in
cells, can influence the anti-HIV activity and cytotoxicity of NRTIs
(Becher et al., 2003; Lund et al., 2007; Steet et al., 2000). It was
demonstrated that hematopoietic toxicity of FLT in vivo was due in
part to its efficient conversion to FLTTP and that FLT induced both
damageandapoptosis inhuman lymphoblastoid cell line (Sundseth
et al., 1996). Several physico-chemical effects, like a decrease in the
pKa values fordissociationofN(3)-Horan increase in thehydropho-
bic properties of the pyrimidine moiety due to the presence of a
sulphur atom, can affect the cell membrane interactions and trans-
port of nucleoside analogues into the mitochondria; this would
influence the anti-HIV activity and cytotoxicity of 4-SFLT and 2-
SFLT (Stahle et al., 1993). Moreover, a decrease in the pKa values
for dissociation of N(3)-H in both 2-SFLT and 4-SFLT as compared
to FLT can reduce the phosphorylation efficiency of the thionucle-
osides by cellular and mitochondrial kinases, thus weakening their
cytotoxicity. It was demonstrated that while both HIV-1 RT and
human pol  exhibit 5′-to-3′ DNA polymerase activity, only DNA
pol  has an intrinsic 3′-to-5′ exonuclease proofreading activity,
which can reduce the toxicity by removal of nucleoside analogues
from DNA termini. Moreover, the rates of the exonuclease exci-
sion of different NRTIs by mitochondrial DNA pol  were found to
vary significantly (Graves et al., 1998; Hanes and Johnson, 2008;
Lee et al., 2003; Lim and Copeland, 2001; Longley et al., 1998). The
presence of a sulphur atom in the pyrimidinemoietymay affect the
exonuclease efficiency of polymerase  for both thionucleosides by
destabilising binding at the polymerase site (Hanes and Johnson,
2008).
It is worth to notice, that besides examined in this work host
polymerases, other cellular polymerases also exposed to triphos-
phate forms of tested thymidine analogues are potential targets
for cytotoxicity. However, Matthes et al. demonstrated poor sen-
sitivity of polymerase  for both 4-SFLTTP and FLTTP with IC50
values of 140M and above 200M, respectively (Matthes et al.,
1987, 1989). Additionally, many other inhibition studies showed
that polymerasewas less sensitive to other thymidine nucleotide
analogues than polymerase andmostly similarly or even less sen-
sitive to suchcompounds thanpolymerase (Faraj et al., 2000;Hart
et al., 1992; Martin et al., 1994; Matthes et al., 1987). Moreover, it
was demonstrated, that both polymerase  and polymerase with
IC50 values for FLTTP over 100M and 200M, respectively (von
Janta-Lipinski et al., 1998), likewise polymerase, weremainly less
sensitive to thymidinenucleotideanalogues thanbothpolymerases
 and  (Focher et al., 1995; Huang et al., 1992; Martin et al., 1994;
Yang et al., 2007).
4. Conclusions
Thepresented results show that both4-SFLTTP and2-SFLTTP are
potent, competitive inhibitors of HIV-1 RT. On the other hand, their
parent nucleosides, 4-SFLT and 2-SFLT exert reduced, in compari-
son to FLT, anti-HIV-1 activity as well as cytotoxicity, in spite of the
high inhibitory activities of their 5′-triphosphates against human
polymerase  (Table 1). Anti-HIV-1 RT inhibitory activities of 5′-
triphosphates of both thiated nucleoside analogues only partially
correlated with the antiviral activities of their parent nucleosides.
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ndicates that 2-SFLT is a potent and selective in vitro anti-HIV-1
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